These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Transglutaminase 2 is associated with adverse colorectal cancer survival and represents a therapeutic target. Malkomes P; Lunger I; Oppermann E; Lorenz J; Faqar-Uz-Zaman SF; Han J; Bothur S; Ziegler P; Bankov K; Wild P; Bechstein WO; Rieger MA Cancer Gene Ther; 2023 Oct; 30(10):1346-1354. PubMed ID: 37443286 [TBL] [Abstract][Full Text] [Related]
11. Transglutaminases are oncogenic biomarkers in human cancers and therapeutic targeting of TGM2 blocks chemoresistance and macrophage infiltration in pancreatic cancer. Zhang S; Yao HF; Li H; Su T; Jiang SH; Wang H; Zhang ZG; Dong FY; Yang Q; Yang XM Cell Oncol (Dordr); 2023 Oct; 46(5):1473-1492. PubMed ID: 37246171 [TBL] [Abstract][Full Text] [Related]
12. Transglutaminase 2 Regulates Self-renewal and Stem Cell Marker of Human Colorectal Cancer Stem Cells. Kang S; Oh SC; Min BW; Lee DH Anticancer Res; 2018 Feb; 38(2):787-794. PubMed ID: 29374703 [TBL] [Abstract][Full Text] [Related]
13. Activation of tissue transglutaminase transcription by histone deacetylase inhibition as a therapeutic approach for Myc oncogenesis. Liu T; Tee AE; Porro A; Smith SA; Dwarte T; Liu PY; Iraci N; Sekyere E; Haber M; Norris MD; Diolaiti D; Della Valle G; Perini G; Marshall GM Proc Natl Acad Sci U S A; 2007 Nov; 104(47):18682-7. PubMed ID: 18003922 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA‑214 suppresses the viability, migration and invasion of human colorectal carcinoma cells via targeting transglutaminase 2. Shan H; Zhou X; Chen C Mol Med Rep; 2019 Aug; 20(2):1459-1467. PubMed ID: 31173203 [TBL] [Abstract][Full Text] [Related]
15. Genomic variants reveal differential evolutionary constraints on human transglutaminases and point towards unrecognized significance of transglutaminase 2. Thangaraju K; Király R; Demény MA; András Mótyán J; Fuxreiter M; Fésüs L PLoS One; 2017; 12(3):e0172189. PubMed ID: 28248968 [TBL] [Abstract][Full Text] [Related]
16. Dopaminylation of histone H3 in ventral tegmental area regulates cocaine seeking. Lepack AE; Werner CT; Stewart AF; Fulton SL; Zhong P; Farrelly LA; Smith ACW; Ramakrishnan A; Lyu Y; Bastle RM; Martin JA; Mitra S; O'Connor RM; Wang ZJ; Molina H; Turecki G; Shen L; Yan Z; Calipari ES; Dietz DM; Kenny PJ; Maze I Science; 2020 Apr; 368(6487):197-201. PubMed ID: 32273471 [TBL] [Abstract][Full Text] [Related]
18. Type 2 transglutaminase in the nucleus: the new epigenetic face of a cytoplasmic enzyme. Rossin F; Ciccosanti F; D'Eletto M; Occhigrossi L; Fimia GM; Piacentini M Cell Mol Life Sci; 2023 Jan; 80(2):52. PubMed ID: 36695883 [TBL] [Abstract][Full Text] [Related]
19. Kaempferol induces ROS-dependent apoptosis in pancreatic cancer cells via TGM2-mediated Akt/mTOR signaling. Wang F; Wang L; Qu C; Chen L; Geng Y; Cheng C; Yu S; Wang D; Yang L; Meng Z; Chen Z BMC Cancer; 2021 Apr; 21(1):396. PubMed ID: 33845796 [TBL] [Abstract][Full Text] [Related]
20. miR-19-Mediated Inhibition of Transglutaminase-2 Leads to Enhanced Invasion and Metastasis in Colorectal Cancer. Cellura D; Pickard K; Quaratino S; Parker H; Strefford JC; Thomas GJ; Mitter R; Mirnezami AH; Peake NJ Mol Cancer Res; 2015 Jul; 13(7):1095-1105. PubMed ID: 25934693 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]